Trial Profile
A Double-Blinded, Randomized Placebo Controlled Pilot Study Comparing the Efficacy and Safety of IncobotulinumtoxinA Versus Saline Injections to the Cheek Region in Patients With Rosacea
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Rosacea
- Focus Adverse reactions; Therapeutic Use
- 20 Aug 2020 Status changed from active, no longer recruiting to completed.
- 21 Apr 2015 New trial record